PDCD1 and glioblastoma: Coexpression of TIGIT and PD-1 on CD8+ TILs, which is associated with dysfunctional antitumor immune responses, has also been observed in cancers such as HCC, glioblastoma (GBM), acute myeloid leukemia, NSCLC, and melanoma (114).